| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |